Once Bitten, Twice Shy

Although the preventive medicine by This Place had gone through the review period, things did not go as smoothly as they had expected. Instead, due to various reasons, the medicine sold was not enough to make up for the money they had invested, especially for Pfizer, which was already on the verge of collapse.

As for Lu Ming Corporation, they had also lost a lot of money. After all, they had taken the lead in this collaboration.

This time, the people from the finance department were finally anxious! They also felt that it was ridiculous. The medicine was clearly close to perfection, so why were there still so many people pestering them? Could it be that they were taking advantage of the company? Ever since the Lu Ming Corporation officially released the medicine, many of their peers were jealous.